Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. (Q48438777)
Jump to navigation
Jump to search
scientific article published on 13 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. |
scientific article published on 13 November 2014 |
Statements
1 reference
Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. (English)
1 reference
Jared M Fine
1 reference
Daniel B Renner
1 reference
Anna C Forsberg
1 reference
Rachel A Cameron
1 reference
Benjamin T Galick
1 reference
Clint Le
1 reference
Patrick M Conway
1 reference
Benjamin M Stroebel
1 reference
William H Frey
1 reference
Leah R Hanson
1 reference
13 November 2014
1 reference
1 reference
584
1 reference
362-367
1 reference
Identifiers
1 reference
1 reference